Search research articles
Contact Us
Filters
Showing results (21-30 of 121) with videos related to
Page
of 13
Sort By:
Gastroenterology
|
March 5, 2017
The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association
Daniel E Freedberg, Lawrence S Kim, Yu-Xiao Yang
Gastroenterology
|
January 16, 2021
Reply
Daniel E Freedberg, Timothy C Wang, Julian A Abrams
Gastroenterology
|
January 2, 2021
Famotidine and Coronavirus Disease 2019
Daniel E Freedberg, Timothy C Wang, Julian A Abrams
Digestive Diseases and Sciences
|
April 13, 2016
Potential Role of the Microbiome in Barrett's Esophagus and Esophageal Adenocarcinoma
Erik J Snider, Daniel E Freedberg, Julian A Abrams
Gastroenterology
|
August 17, 2015
Proton Pump Inhibitors and Myocardial Infarction
Daniel E Freedberg, Yu-Xiao Yang, Julian A Abrams
Journal of the National Cancer Institute
|
June 14, 2014
Prevention of gastric cancer with antibiotics: can it be done without eradicating Helicobacter pylori?
Daniel E Freedberg, Julian A Abrams, Timothy C Wang
Digestive Diseases and Sciences
|
February 19, 2021
A Simple Emergency Department-Based Score Predicts Complex Hospitalization in Patients with Inflammatory Bowel Disease
Abhishek Verma, Sanskriti Varma, Daniel E Freedberg, et al.
The American Journal of Gastroenterology
|
April 5, 2014
Response to Abdallah et al
Daniel E Freedberg, Hojjat Salmasian, Carol Friedman, et al.
The American Journal of Gastroenterology
|
June 5, 2014
Response to Daniell
Daniel E Freedberg, Hojjat Salmasian, Carol Friedman, et al.
Inflammatory Bowel Diseases
|
March 14, 2023
Proton pump Inhibitors and Risk of Enteric Infection in Inflammatory Bowel Disease: A Self-controlled Case Series
Sanskriti Varma, Stephen J Trudeau, Jianhua Li, et al.
Page
of 13
Search research articles
Search
Showing results (21-30 of 121) with videos related to
Sort By:
Page
of 13
Gastroenterology
|
March 5, 2017
The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association
Daniel E Freedberg, Lawrence S Kim, Yu-Xiao Yang
Gastroenterology
|
January 16, 2021
Reply
Daniel E Freedberg, Timothy C Wang, Julian A Abrams
Gastroenterology
|
January 2, 2021
Famotidine and Coronavirus Disease 2019
Daniel E Freedberg, Timothy C Wang, Julian A Abrams
Digestive Diseases and Sciences
|
April 13, 2016
Potential Role of the Microbiome in Barrett's Esophagus and Esophageal Adenocarcinoma
Erik J Snider, Daniel E Freedberg, Julian A Abrams
Gastroenterology
|
August 17, 2015
Proton Pump Inhibitors and Myocardial Infarction
Daniel E Freedberg, Yu-Xiao Yang, Julian A Abrams
Journal of the National Cancer Institute
|
June 14, 2014
Prevention of gastric cancer with antibiotics: can it be done without eradicating Helicobacter pylori?
Daniel E Freedberg, Julian A Abrams, Timothy C Wang
Digestive Diseases and Sciences
|
February 19, 2021
A Simple Emergency Department-Based Score Predicts Complex Hospitalization in Patients with Inflammatory Bowel Disease
Abhishek Verma, Sanskriti Varma, Daniel E Freedberg, et al.
The American Journal of Gastroenterology
|
April 5, 2014
Response to Abdallah et al
Daniel E Freedberg, Hojjat Salmasian, Carol Friedman, et al.
The American Journal of Gastroenterology
|
June 5, 2014
Response to Daniell
Daniel E Freedberg, Hojjat Salmasian, Carol Friedman, et al.
Inflammatory Bowel Diseases
|
March 14, 2023
Proton pump Inhibitors and Risk of Enteric Infection in Inflammatory Bowel Disease: A Self-controlled Case Series
Sanskriti Varma, Stephen J Trudeau, Jianhua Li, et al.
Page
of 13